MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

June 2013



Part 2: Potential Concerns and Challenges for P&T Committees

P&T committee members need a lot more information before they can evaluate the efficacy and safety, interchangeability, and cost-effectiveness of biosimilar products for inclusion on formularies.
C. Lee Ventola, MS

Polycystic Ovary Syndrome

A Review of Treatment Options With a Focus on Pharmacological Approaches

Oral contraceptives, antidiabetes drugs, and statins are some of the therapies used to address the symptoms of this complex hormonal condition. Weight loss and surgery may also be beneficial as non-drug options.
Uche Anadu Ndefo, PharmD, BCPS; Angie Eaton, PharmD; and Monica Robinson Green, PharmD, BCPS, BCACP

Pharmacovigilance Forum

Drug-Induced Pancreatitis

A Potentially Serious and Underreported Problem

There have been many published reports of possible cases of drug-induced pancreatitis. In addition, some disease states and patient characteristics predispose particular populations to the development of this condition. Three case histories are presented.
Michele B. Kaufman, PharmD, RPh

Meeting Highlights

48th European Association for the Study of the Liver and American Association for Cancer Research

Therapies for hepatitis C include sofosbuvir; an interferon-free triple regimen; and an investigational agent, MK-5172. Ramucirumab for gastric and gastroesophageal junction cancers and an everolimus/exemestane combination for breast cancer are also discussed.
Walter Alexander


Medication Errors

Multiple Brand Names for the Same Generic Drug Can Cause Confusion

Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medicare Changes Include New Part D Rules and Possible Cuts to Hospitals

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Extended-release carbinoxamine maleate oral suspension (Karbinal ER) for allergic rhinitis; brinzolamide 1.0%/brimonidine tartrate 0.2% ophthalmic suspension (Simbrinza) for open-angle glaucoma and ocular hypertension; and cysteamine bitartrate (Procysbi) for nephropathic cystinosis
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Nuedexta for the Treatment of Pseudobulbar Affect

A Condition of Involuntary Crying or Laughing

Dextromethorphan/quinidine (Nuedexta) for pseudobulbar affect
Martin Paspe Cruz, PharmD, CGP, BCPP